Assessment of micafungin loading dosage regimens against Candida spp. in ICU patients by Monte Carlo simulations
Authors:
- 11 February 2020
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 76 (5) , 695-702
Abstract
To assess the efficacy of loading dose on micafungin by simulating different dosage regimens.Keywords
This publication has 29 references indexed in Scilit:
- Clinical Pharmacokinetics and Pharmacodynamics of MicafunginClinical Pharmacokinetics, 2017
- Relationship between the Effectiveness and Dose of Micafungin in the Treatment of CandidemiaYAKUGAKU ZASSHI, 2014
- Moxifloxacin Population Pharmacokinetics and Model-Based Comparison of Efficacy between Moxifloxacin and Ofloxacin in African PatientsAntimicrobial Agents and Chemotherapy, 2014
- In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida SpeciesAntimicrobial Agents and Chemotherapy, 2010
- International Study of the Prevalence and Outcomes of Infection in Intensive Care UnitsJAMA, 2009
- Increasing incidence of Candida parapsilosis candidemia with caspofungin usageJournal of Infection, 2008
- Clinical Practice Guidelines for the Management of Sporotrichosis: 2007 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2007
- Relationship between the initial dose of micafungin and its efficacy in patients with candidemiaJournal of Infection and Chemotherapy, 2007
- A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantationBone Marrow Transplantation, 2006
- Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugsInternational Journal of Antimicrobial Agents, 2002